new therapies and disease management. 3 Although these novel therapies are targeting and improving outcomes in younger CF populations and in subgroups with specific CF genotypes, 4 there is a shortage of sensitive biomarkers able to regionally monitor disease progression and to assess early responses to therapy over a broad range of phenotypes.
Magnetic resonance imaging (MRI) and computed tomography (CT) are sensitive to early morphological changes in the CF lung 5, 6 and, combined with CF-specific scoring systems, provide outcome measures for clinical trials and for quantitative disease monitoring of individual patients. 5, 6 However, both scoring systems and training are subjective and time-consuming for radiologists. 7 More automated and objective measures of CF lung disease have been proposed, such as air trapping quantification by CT, 8 lung perfusion and blood flow dysfunction assessment by proton-MRI ( 1 H-MRI), 9 and regional ventilation measure by hyperpolarized-MRI. 10, 11 Recently, multivolume noncontrast-enhanced 1 H-MRI, 12, 13 and CT 14, 15 techniques, which assess the regional intensity changes between breath-hold images acquired at different lung volumes, have been introduced to infer regional ventilation, demonstrating sensitivity to ventilation heterogeneities related to gravitational effects in healthy lung and to ventilation defects caused by emphysema and asthma. [12] [13] [14] [15] The present study was designed to assess the feasibility of multivolume noncontrast-enhanced MRI and CT, to detect and quantify regional ventilation abnormalities in CF lung disease, with a focus on the structure-function relationship. In particular, we aimed to: 1) investigate MR signal-intensity change in healthy lung and CF lung disease; 2) describe the correlation between the MR signal-intensity and the CT-density change; and 3) globally and locally investigate any relationship between the structural abnormalities (quantified by a CF-specific lung disease score) and the functional impairment (quantified by multivolume imaging).
Materials and Methods

Study Subjects
The current HIPAA-compliant study was approved by our Institutional Review Board (IRB), and informed written consent/assent was obtained from each subject and/or guardians of the participants. Young children (n 5 10, 4F/6M, age 23 6 12 months) and adolescents (n 5 6, 2F/4M, age 13 6 4 years) with CF lung disease, and age-matched healthy young children (n 5 9, 5F/4M, 21 6 10 months) and adolescents (n 5 4, 2F/2M, 16 6 4 years), were included in the study (29 total subjects, Table 1 ).
The diagnosis of CF was based on established diagnostic criteria 16 including clinical symptoms consistent with CF and confirmed by sweat chloride >60 mM and/or two CF causing mutations in the CFTR gene. 17 Patients are detailed in Table 2 .
Age-matched healthy subjects were selected from our database of patients undergoing clinical MRI of the central nervous system, excluding those subjects with pulmonary symptoms or a history of lung disease. CF patients underwent MR and CT imaging as part of their annual check-up. Only MRI was available for healthy subjects, as CT scans could not be ethically performed without a clinical indication. Breath-hold images were acquired at end-inspiration approximating total lung capacity (TLC) and end-expiration approximating functional residual capacity (FRC). As per routine clinical imaging, young children were intubated and ventilated during imaging, with TLC and FRC scans acquired using airway pressures of 30 and 0 cm water, respectively, after lung recruitment maneuvers to reduce atelectasis. Adolescents were coached to hold their breath at TLC and FRC.
CT Image Acquisition
Noncontrast axial volume scans were performed using an Aquilion ONE (Toshiba Medical Systems, Tustin, CA) 320-slice CT scanner with patients' arms up. A weight-based CT technique was used to minimize radiation dose. 18 Imaging parameters were: tube voltage, 80-100 kVp; tube current, 40-145 mA; automatic tube current modulation; matrix, 512 3 512; slice thickness, 0.5 mm; slice gap: 3-5 mm; reconstruction kernel, FC18; reconstruction algorithm: AIDR (Adaptive Iterative Dose Reduction) 3D iterative reconstruction. 
Image Processing
From the MRI and the CT scans acquired at TLC and FRC, six correspondent slices at the same apical-basal level of the lung were manually selected. MRI lung-signal intensity was normalized to the mean heart signal (tissue1blood) to eliminate the effect of H-MR and CT images were semiautomatically segmented to separate lung parenchyma from the surrounding soft tissues, using MIPAV software (Medical Image Processing, Analysis and Visualization) 20 . Next, at each lung level, the expiratory MR and CT images were automatically deformed to the corresponding inspiratory images using the Lucas-Kanade 2D optical-flow algorithm. 21 To make registration more sensitive to structure rather than overall intensity (which changes with lung volume), the input images were preprocessed using a Laplacian filter. 13, 15 Laplacian was obtained by a 3-by-3 (for MR images) and 5-by-5 (for CT images) image filter approximating the shape of the 2D Laplacian operator. 2D maps of the normalized MR signal-intensity difference
H TLC ) and of CT density-difference (DHU 5 HU FRC -HU TLC ) were obtained using pixel-by-pixel subtraction between the two registered images.
Image processing and quantitative analysis were performed by custom software developed in MatLab (MathWorks, Natick, MA). H-MRI and DHU were evaluated in six corresponding regions at six equally spaced lung levels (36 corresponding values for each subject).
Image Analysis
GLOBAL STRUCTURE-FUNCTION RELATIONSHIP. MR and CT images were independently scored by two senior pediatric radiologists trained in pulmonary image analysis and CF-specific scoring, according to previously validated and published scoring systems. 6, 22, 23 All identifying information was removed and the images were read in random order. Overall score and subscores were reported as mean values of the two readers' scores. The lungs were divided into six lobar regions (five lobes plus lingula) and assessed for consolidation, ground glass opacity, mucus plugging, bronchial wall thickening, bronchiectasis (on inspiratory-scans), and air trapping (on expiratory-scans). 24 The extent of each abnormality was scored on a 0-2 scale (0 5 not present, 1 < 1 =2 lobe, 2 > 1 =2 lobe) for each of these parameters in each of the lobar regions, with a maximum score of 72. The total scores of the left and right lungs were reported separately. Global functional changes were evaluated by computing the median value of D 1 H-MRI and of DHU across the six lung levels in the left and right lung.
H-MRI and DHU were measured in regions of interest (ROIs, about 100-mm 2 -area circles) selected in each lobe according to radiological findings, avoiding large vessels and airways, through matching of axial slices and in-plane anatomical positions of MRI and CT ROIs (according to the indications of the radiologists, ROIs were selected by F.P., with a PhD degree in Bioengineering and 7 years of experience in MR and CT pulmonary imaging). Regions of consolidation, ground glass opacity, and air trapping were selected within the impaired parenchyma. Regions of bronchial wall thickening, bronchiectasis, and mucus plugging were selected in segments of lung distal to the abnormality. Healthy regions were selected in lobes with no radiological abnormalities (lobar CFspecific score 5 0 Post-hoc tests were based on Holm-Sidak and Dunn methods respectively for parametric and nonparametric ANOVA tests. Significance was determined using a difference with P < 0.05. Figure 1 displays D 1 H-MRI maps in representative healthy and CF subjects at six equally-spaced levels from diaphragm apex to aortic arch. In healthy subjects, we observed: 1) higher D 1 H-MRI in the young child (up to 50% of the mean heart signal, Fig. 1a , top) compared to the adolescent (up to 30% of the mean heart signal, Fig. 1b, top) ; 2) clear gravitational effects with increasing values from ventral to dorsal regions in both subjects. In the young child with CF (Fig. 1a , bottom) we still observed D 1 H-MRI values of up to 50% of the mean heart signal and gravitational effects, but also D 1 H-MRI asymmetries between the left and the right lung, with lower values in the right lung. In the CF adolescent (Fig. 1b, bottom) , D 1 H-MRI was below 10% of the mean heart signal and no gravitational effects were visible. Lung-thirds analysis (Fig. 1c) demonstrates 1) strong gravity-dependence of D 1 young children (both healthy and CF, P < 0.001) and healthy adolescents (P < 0.05); 2) higher D 1 H-MRI in young children compared to adolescents (P < 0.001); and 3) in adolescents, higher median D Boxes indicate 25 th percentile, median, and 75 th percentile of the values calculated in all subjects. *P < 0.05. ***P < 0.001.
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Global Structure-Function Relationship Figure 4 displays representative CF-specific lung abnormalities: air trapping, consolidation, ground glass opacity, bronchial-wall thickening, bronchiectasis, and mucus plugging in both CT (I, II columns) and MR images (III, IV columns) at FRC (I, III columns) and TLC (II, IV columns). Figure 5 shows DHU (Fig. 5a ) and D 1 H-MRI (Fig. 5b) decrease with increasing overall CF-specific lung disease score in both young CF children and CF adolescents. Table 3 reports the correlation coefficients (R 2 ) between DHU and D 1 H-MRI to the total CF-specific score.
Local Structure-Function Relationship Figure 6 shows that at FRC (Fig. 6a,c) median HU and 1 H-MRI decreased significantly in bronchiectasis, air trapping, and mucus plugging ROIs compared to healthy; conversely, at TLC (Fig. 6b,d) , HU and 1 H-MRI increase significantly in consolidation ROIs. Figure 7 shows a nearly quadratic relationship between D 1 H-MRI and DHU (R 2 5 0.76, P < 0.001) with higher values in healthy regions (black) compared to CF abnormalities (colored). DHU (Fig. 7b) and D 1 H-MRI (Fig. 7c) were higher in healthy compared to bronchiectasis, air trapping, and consolidation ROIs (P < 0.001). Furthermore, 
Discussion
The current study demonstrated that multivolume MRI and CT techniques, which infer ventilation as expiratoryinspiratory MR signal-intensity and CT density change, respectively, can localize and differentiate among different ventilation defects in CF lung disease, and that this functional impairment is directly related to structural abnormalities. Multivolume noncontrast MRI, as a nonionizing technique, is a promising tool in CF care, which requires lifelong monitoring. Although this technique suffers from low signal-to-noise ratio, compared to gaseous tracer techniques, 25 it can be used on nearly any 1.5T MRI scanner, and doesn't require the specialized apparatus and technology of those alternative techniques. Expiratory-inspiratory noncontrast-enhanced MR and CT imaging has been recently proposed as an alternative to current ventilation-imaging techniques, such as nuclear imaging, xenon-enhanced CT, and hyperpolarized-MRI, due to their high cost and/or translatability to ordinary clinical practice. [25] [26] [27] Expiratory-inspiratory noncontrast-enhanced techniques are based on a simplified two-compartment model of the lung: a fixed volume of lung tissue and a variable amount of air. During inspiration, parenchymal tissue expands and becomes less dense, leading to an inflow of air due to the near incompressibility of gas at physiologic pressures. Therefore, the tissue density reduction has to be equal to the air that entered the lung, thus closely related to ventilation. We note that in MRI the signal intensity includes not only lung tissue, but also the blood volume, which varies with heartbeat.
Nevertheless, with breath-hold acquisitions we are sufficiently longer than the time between heartbeats; thus, averaging over time, the technique ensures a consistent blood volume. Previous multivolume MRI and CT studies have demonstrated sensitivity to physiological and pathophysiological phenomena (such as gravity dependence, tissue destruction, and collateral ventilation) in healthy and obstructive lung disease. [12] [13] [14] [15] Ventilation defects are indicated by little to no change in MR signal-intensity and CT density between inspiratory and expiratory images. In healthy controls, large changes in MR signal-intensity 13 and CT density 28 between inspiration and expiration images indicate normal lung function. In CF, lung parenchyma can be altered by airway obstruction, gas trapping, and consolidation, with pulmonary FIGURE 4: CF-specific findings in the CT (first and second column) and MR images (third and fourth column), at FRC (first and third column) and TLC (second and fourth column). The radiological findings include: healthy region (H), region with bronchial wall thickening (BWT), mucus plugging (MP), bronchiectasis (B), air trapping (AT), consolidation (C), and ground glass opacity (GGO). The red circle in the first column represents the ROI selected. In case of airway-related impairment, a red arrow indicates the airway and the red circle the ROI.
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Month 2018deterioration due to inflammatory processes and chronic infections in airways, resulting in permanent structural change and regions with low/no gas volume change. In the CF patients examined here, there was a smaller change in MR signal-intensity and CT density between inspiration and expiration images compared to controls, with significant regional differences in the CF lung. This is consistent with investigations of spatial heterogeneity of ventilation in young CF patients with hyperpolarized gases 10, 11 and consistent with temporal heterogeneity via lung clearance index. 29 MR signalintensity changes were found to be highly correlated to CTdensity changes with a nonlinear relationship. Pennati et al 13 previously reported that MR signal-intensity difference maps positively correlate with hyperpolarized 3 He-MRI in healthy volunteers, asthmatic, and emphysematous patients, showing that signal voids in 3 He-MRI corresponded to a MR signalintensity difference of about 5%. Therefore, multivolume MRI cannot differentiate among regions where expiratoryinspiratory intensity change is lower than 5%, as these regions correspond to areas with no ventilation and no signal-intensity variation between expiration and inspiration, thus leading to regions dominated by noise. On the contrary, CT multivolume imaging is able to differentiate among regions with lung density difference below 100 HU.
14 The different behavior of MR and CT imaging at low values of image intensity differences resulted in a nonlinear relationship between the two imaging modalities, with multivolume MR imaging showing a flat behavior below 5%. We attribute this low sensitivity of multivolume MR imaging to the low MR signal-to-noise ratio (SNR) in the parenchyma (2 to 5), due to the short T 2 * of the lungs. At 1.5T, the T 2 * of the lungs is 2.11 msec 30 and with an echo time of 1.2 msec this translates into a 43% reduction in the maximal potential signal of the lungs at an echo time of zero. Increasing SNR is fundamental to provide clear contrast in regions of low ventilation. SNR improvement relies mainly in reducing the echo time, which is possible through the use of ultrashort echo time (UTE) sequences. 31 Moreover, the contrast among the low ventilated regions would be enhanced by acquiring the expiratory image at residual volume (RV) instead of FRC, as previously reported 13 ; nevertheless, much effort would be required by the patient to maintain breath-hold at RV. Yet the lack of MR signal-intensity change observed in the CF patients compared to the controls still suggests that MRI is sensitive in picking up ventilation defects.
There was a high correlation between D 1 H-MRI and FEV 1 % predicted in the adolescent population. Although Journal of Magnetic Resonance Imaging this result was obtained on a small group of patients (n 5 9) and has to be further investigated on more subjects, it suggests that D 1 H-MRI median is highly related to the overall lung ventilation. Furthermore, the relationship between ventilation maps and FEV 1 % predicted in adolescents (who were able to perform the test) advocates for the application of multivolume MRI in infants and young children to monitor early pulmonary function changes, as pulmonary function tests in these patients are difficult to perform and are not routinely clinically ordered.
Both MR signal-intensity and CT-density change were higher in young children compared to adolescents; we believe this is directly related to lung density decline at FRC in the first 2 years of life, 32 in accordance with the hypothesis that in postnatal lung growth, although the number of alveoli increases rapidly, the concurrent process of septation of the developing airspaces into smaller units decreases the gas volume per gram of tissue.
33
MR and CT intensity difference maps significantly correlated with CF-specific score: with increasing structural impairment (ie, increasing disease score) global ventilation decreased, indicating a clear structure-function relationship, detectable even in early CF lung disease. Considering separately the structural abnormalities, two different effects were appreciated: lower density at FRC associated with air trapping and airways-related impairments such as bronchiectasis, bronchial wall thickening, and mucus plugging indicated that the lungs are not properly deflating at FRC; conversely, higher density at TLC, associated with consolidations and ground glass opacities indicated that these regions were not properly inflating. Both of these broad categories of CF lung abnormalities contribute to the lowering of local ventilation. Multivolume imaging therefore has the potential for future regional structure-function correlations across specific CF pathology.
CT has emerged as the "gold standard" for the assessment of early morphological changes of the airways and lung parenchyma in CF, [21] [22] [23] 34 but the exposure to ionizing radiation limits its use in pediatrics and in longitudinal studies. Recent advances in MRI, in particular the advent of UTE-sequences, have made MRI comparable to CT in detecting morphological changes in the CF lung. 5, 35 In addition to visualizing lung pathologies, UTE MRI has also demonstrated its ability quantify lung parenchyma density comparable to CT lung density measurements made in the same subject. 36 Nevertheless, a gap still exists between monitoring the structural damage and assessing the functional impairment, which is critical in CF care. Studies have been performed to assess potential functional biomarkers in CF via CT, 8 oxygen-enhanced-MRI, 9 and hyperpolarized 3 Heand 129 Xe-MRI. 10, 11 Noncontrast-enhanced MRI has been proposed in recent years as a surrogate for regional ventilation. Zapke et al 12 first proposed extracting ventilation images by following the signal changes occurring between breath-hold images on a low-field scanner (0.2T). The original method was further developed to be used in a standard clinical setting, based on GRE acquisitions on a 1.5T MR unit. 13 Bauman et al 37 introduced the Fourier decomposition technique to infer ventilation and perfusion images from a dynamic acquisition in free breathing. As the original Fourier decomposition approach provides qualitative ventilation maps, multiple improvements have been proposed and validated to quantify lung ventilation. [38] [39] [40] Nevertheless, this technique is sensitive to irregularities in breathing and/or heart rate during the acquisition, which widens the ventilation and perfusion spectral lines of the Fourier decomposition, which degrades the quantitative analysis. 40 In the present study we adopted breath-hold GRE acquisitions averaged over many heartbeats, 13 demonstrating that this technique is able to quantitatively differentiate pathological patterns in the CF lung, in accordance with CT registration-based ventilation imaging. In this context, our data show that multivolume imaging techniques can provide contemporary sensitivity to structural and functional impairment necessary to personalize treatment and study the efficacy of emerging therapies. These analyses also have the potential to increase our understanding of structure-function relationships at the earliest stages of disease, revealing the potential of multivolume imaging, in particular MRI, as a tool in the lifelong monitoring of a CF patient's lung function in addition to other standard clinical measures. We expect further improvement in MR-intensity difference maps through the use of UTE-images. At the time of this study, UTE images were acquired during freebreathing and gated to capture images at expiration, thus not providing both the expiratory and the inspiratory images necessary to obtain the intensity difference maps. Multivolume UTE images have been recently proposed by Higano et al, 41 which would provide an initial basis to perform multivolume UTE MR intensity difference maps. Nevertheless, in the present work we investigated the use of a commercially available standard "short-T E " GRE sequence, because it allowed us to quickly capture static breath-hold images at different lung volumes and is immediately translatable to the clinic. Moreover, the image registration algorithm, based on preprocessing the images with a Laplacian filter to overcome the requirement of gray intensity constancy of the optical flow method, is completely automatic, with the segmented images as the only input (no parameter setting required), thus making it ideal for everyday clinical use. Further software development is required to automate the CF lung segmentation, as the structural heterogeneity characterizing this disease prevented the use of the current developed 3D segmentation algorithms. 13, 28 The semiautomatic 2D lung segmentation prevented the use of the 3D optical flow algorithm for image deformation. The through-plane motion was minimized by accurately selecting the images to be registered at the same apical-caudal level, ie, at the same level of the airways' and vessels' trees. Limitations of this study include the relatively low number of patients and the absence of CT images in controls, as CT is not routinely acquired on healthy subjects without an underlying medical condition, especially in pediatrics. Nevertheless, in our ROI analysis healthy lung was selected in regions with no defects and served as an internal control reference value for each individual subject. Our internal control reference values were comparable to those previously reported in healthy control subjects. 28 Also, the range of disease in our study group was broad enough to capture data from subjects with minimal to moderate disease, but with the majority demonstrating little detectable disease. Another limitation is the absence of infant pulmonary function tests, which require either anesthesia or sedation and are not generally acquired clinically.
The main limitation of multivolume imaging is the potential for motion artifacts, especially in MRI scans. The breath-hold requirement of 10-20 seconds, even if well tolerated by our adolescents, could be challenging in patients with advanced disease. Moreover, to introduce the method in clinical practice, volume control would need standardization to ensure image acquisition at the same lung volume, since the amount of mass-density and proton-density variation is strongly dependent on the volume variation between the two scans. We expect to overcome motion-related issues with the recently proposed technique of retrospective motion tracking and respiratory gating, 41 which captures MR images at different stages of respiration with no requirement for breathholds, sedation, or anesthesia during neonatal imaging.
In conclusion, our results provide an initial basis for understanding regional structure-function relationships and employing multivolume imaging in the monitoring of CF lung disease, with clear spatial heterogeneity in ventilation maps in early CF lung disease. Overall, multivolume MRI is potentially valuable in CF care as an imaging modality that can be used for longitudinal monitoring throughout life. These results provide easily translatable imaging biomarkers to detect early alterations in regional structure-function relationships and to improve individualized patient care.
